4519:TYO
Chugai Pharmaceutical Co Ltd
Â¥6,746.00
arrow_upward
+0.93%(+62.00) 1D
Sep 18, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
Â¥6,700
High
Â¥6,755
Low
Â¥6,659
Mkt. cap
11.33T
Avg. vol.
2.35M
Volume
2.85M
Dividend
2.05%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
23.55
52-wk high
Â¥10,700
52-wk low
Â¥6,250
EPS
Â¥286
Shares outstanding
547.19M
No. of employees
5K
Open
Â¥6,700
High
Â¥6,755
Low
Â¥6,659
Mkt. cap
11.33T
Avg. vol.
2.35M
Volume
2.85M
Dividend
2.05%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
23.55
52-wk high
Â¥10,700
52-wk low
Â¥6,250
EPS
Â¥286
Shares outstanding
547.19M
No. of employees
5K
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp